News
VIVUS to Present at Two Financial Conferences in March
MOUNTAIN VIEW, Calif.-(Business Wire)-March 14, 2008 - VIVUS, Inc. (NASDAQ: VVUS) a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that Timothy Morris, vice president and CFO, will present an overview of the company at the following conferences: -0- *T — Cowen and Company 28th Annual Healthcare Conference Location: The Boston Marriott Copley Place, Boston Presentation date: Thursday, March 20 Presentation time: 10:15am E.T. — The BioCentury and Thomson Financial 15th Annual Future Leaders in the Biotech Industry Location: The Millenium Broadway Hotel, New York Presentation Date: Thursday, March 27, 2008 Presentation time: 3:00pm E.T. *T
A live webcast and 30-day archive of these presentations will be available at http://www.vivus.com.
About VIVUS
VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products. The current portfolio includes investigational products addressing obesity and sexual health. The pipeline includes: Qnexa(TM), which is in phase 3, for the treatment of obesity and phase 2 for the treatment of type 2 diabetes; Luramist(TM) (Testosterone MDTS(R)), for which a phase 2 study has been completed for the treatment of Hypoactive Sexual Desire Disorder (HSDD); and avanafil, for which a phase 2 study has been completed for the treatment of erectile dysfunction (ED). MUSE(R) is approved and currently on the market for the treatment of ED. For more information on clinical trials and products, please visit the company's web site at http://www.vivus.com/.
Search Our News Using Google Search
Can't find what you want? Try using Google:
